Top

International Journal of Colorectal Disease

Published in:

01-12-2007 | Original Article

C-reactive protein as early predictor for infectious postoperative complications in rectal surgery

Authors: T. Welsch, S. A. Müller, A. Ulrich, A. Kischlat, U. Hinz, P. Kienle, M. W. Büchler, J. Schmidt, B. M. Schmied

Published in: International Journal of Colorectal Disease | Issue 12/2007

Abstract

Background

This study evaluated the role of the acute phase C-reactive protein (CRP) in the postoperative course of a large series of rectal resections on the basis of a prospective database. Main focus of this study was the early identification of complications.

Materials and methods

Three hundred eighty-three rectal resections with primary anastomosis for rectal cancer were screened for infectious postoperative complications. Forty-eight complicated cases were identified and matched with 48 patients with an uneventful postoperative course.

Results

In the postoperative setting, CRP peaked on postoperative day (POD) 2 with a median serum CRP of 140 mg/l and gradually declined thereafter in uncomplicated cases. In complicated cases, CRP elevation generally persisted after POD 2, whereas white blood cells and body temperature were within normal range in the early postoperative period. A cutoff CRP value of 140 mg/dl on PODs 3 and 4 resulted in predictive values of 85.7 and 90.5% (adjusted to the prevalence: 37.6 and 50.3%), sensitivities of 80.0 and 54.3%, and specificities of 81.0 and 92.3% for a complicated postoperative course (P < 0.001), respectively.

Conclusion

Persistent CRP elevation and elevation of serum CRP above 140 mg/dl on PODs 3–4 are predictive of infectious postoperative complications and should prompt intense clinical search for an inflammatory process, especially for an anastomotic leak if pneumonia and wound infection are unlikely or excluded.

Tillet WS, Francis T (1930) Serological reactions in pneumonia with a non-protein somatic fraction of the pneumococcus. J Exp Med 52:561–571CrossRef

Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448–454CrossRefPubMed

Bang R, Marnell L, Mold C, Stein MP, Clos KT, Chivington-Buck C, Clos TW (2005) Analysis of binding sites in human C-reactive protein for FcγRI, FcγRIIA, and C1q by site-directed mutagenesis. J Biol Chem 280:25095–25102CrossRefPubMed

Venugopal SK, Devaraj S, Jialal I (2005) Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role. Curr Opin Nephrol Hypertens 14:33–37CrossRefPubMed

Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Invest 111:1805–1812CrossRefPubMedPubMedCentral

Vermeire S, Van Assche G, Rutgeerts P (2006) Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 55:426–431CrossRefPubMedPubMedCentral

Koenig W (2005) Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein. Int J Cardiol 98:199–206CrossRefPubMed

Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A (1994) The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 331:417–424CrossRefPubMed

Yeh ET (2004) CRP as a mediator of disease. Circulation 109:II11–4CrossRefPubMed

10.

Best LG, Zhang Y, Lee ET, Yeh JL, Cowan L, Palmieri V, Roman M, Devereux RB, Fabsitz RR, Tracy RP, Robbins D, Davidson M, Ahmed A, Howard BV (2005) C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: the Strong Heart Study. Circulation 112:1289–1295CrossRefPubMed

11.

Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387–1397CrossRefPubMed

12.

Jamieson NB, Glen P, McMillan DC, McKay CJ, Foulis AK, Carter R, Imrie CW (2005) Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas. Br J Cancer 92:21–23CrossRefPubMed

13.

Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ (2004) C-reactive protein and the risk of incident colorectal cancer. JAMA 291:585–590CrossRefPubMed

14.

Helzlsouer KJ, Erlinger TP, Platz EA (2006) C-reactive protein levels and subsequent cancer outcomes: Results from a prospective cohort study. Eur J Cancer 42:704–707CrossRefPubMed

15.

Hashimoto K, Ikeda Y, Korenaga D, Tanoue K, Hamatake M, Kawasaki K, Yamaoka T, Iwatani Y, Akazawa K, Takenaka K (2005) The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer 103:1856–1864CrossRefPubMed

16.

Buchler M, Malfertheiner P, Schoetensack C, Uhl W, Beger HG (1986) Sensitivity of antiproteases, complement factors and C-reactive protein in detecting pancreatic necrosis. Results of a prospective clinical study. Int J Pancreatol 1:227–235PubMed

17.

Werner J, Hartwig W, Uhl W, Muller C, Buchler MW (2003) Useful markers for predicting severity and monitoring progression of acute pancreatitis. Pancreatology 3:115–127CrossRefPubMed

18.

Reith HB, Mittelkotter U, Debus ES, Kussner C, Thiede A (1998) Procalcitonin in early detection of postoperative complications. Dig Surg 15:260–265CrossRefPubMed

19.

Mustard RA Jr, Bohnen JM, Haseeb S, Kasina R (1987) C-reactive protein levels predict postoperative septic complications. Arch Surg 122:69–73CrossRefPubMed

20.

Morley JJ, Kushner I (1982) Serum C-reactive protein levels in disease. Ann N Y Acad Sci 389:406–418CrossRefPubMed

21.

Their M, Ronnholm K, Sairanen H, Holmberg C, Jalanko H (2002) Serum C-reactive protein in pediatric kidney and liver transplant patients. Pediatr Transplant 6:153–160CrossRefPubMed

22.

Wullstein C, Drognitz O, Woeste G, Schareck WD, Bechstein WO, Hopt UT, Benz S (2004) High levels of C-reactive protein after simultaneous pancreas–kidney transplantation predict pancreas graft-related complications and graft survival. Transplantation 77:60–64CrossRefPubMed

23.

Karanjia ND, Corder AP, Bearn P, Heald RJ (1994) Leakage from stapled low anastomosis after total mesorectal excision for carcinoma of the rectum. Br J Surg 81:1224–1226CrossRefPubMed

24.

Law WL, Chu KW (2004) Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients. Ann Surg 240:260–268CrossRefPubMedPubMedCentral

25.

Nesbakken A, Nygaard K, Lunde OC, Blucher J, Gjertsen O, Dullerud R (2005) Anastomotic leak following mesorectal excision for rectal cancer: true incidence and diagnostic challenges. Colorectal Dis 7:576–581CrossRefPubMed

26.

Pakkastie TE, Luukkonen PE, Jarvinen HJ (1994) Anastomotic leakage after anterior resection of the rectum. Eur J Surg 160:293–297PubMed

27.

Vignali A, Fazio VW, Lavery IC, Milsom JW, Church JM, Hull TL, Strong SA, Oakley JR (1997) Factors associated with the occurrence of leaks in stapled rectal anastomoses: a review of 1,014 patients. J Am Coll Surg 185:105–113CrossRefPubMed

28.

Alberts JC, Parvaiz A, Moran BJ (2003) Predicting risk and diminishing the consequences of anastomotic dehiscence following rectal resection. Colorectal Dis 5:478–482CrossRefPubMed

29.

Nesbakken A, Nygaard K, Lunde OC (2001) Outcome and late functional results after anastomotic leakage following mesorectal excision for rectal cancer. Br J Surg 88:400–404CrossRefPubMed

30.

Yamamoto S, Fujita S, Akasu T, Moriya Y (2004) A comparison of the complication rates between laparoscopic colectomy and laparoscopic low anterior resection. Surg Endosc 18:1447–1451CrossRefPubMed

31.

Millan M, Garcia-Granero E, Flor B, Garcia-Botello S, Lledo S (2006) Early prediction of anastomotic leak in colorectal cancer surgery by intramucosal pH. Dis Colon Rectum 49:595–601CrossRefPubMed

32.

Yentis SM, Soni N, Sheldon J (1995) C-reactive protein as an indicator of resolution of sepsis in the intensive care unit. Intensive Care Med 21:602–605CrossRefPubMed

33.

Claeys R, Vinken S, Spapen H, ver Elst K, Decochez K, Huyghens L, Gorus FK (2002) Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates. Crit Care Med 30:757–762CrossRefPubMed

34.

Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schuttler J (1998) Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 24:680–684CrossRefPubMed

35.

Sarbinowski R, Arvidsson S, Tylman M, Öresland T, Bengtsson A (2005) Plasma concentration of procalcitonin and systemic inflammatory response syndrome after colorectal surgery. Acta Anaesthesiol Scand 49:191–196CrossRefPubMed

Title: C-reactive protein as early predictor for infectious postoperative complications in rectal surgery
Authors: T. Welsch
S. A. Müller
A. Ulrich
A. Kischlat
U. Hinz
P. Kienle
M. W. Büchler
J. Schmidt
B. M. Schmied
Publication date: 01-12-2007
Publisher: Springer Berlin Heidelberg
Published in: International Journal of Colorectal Disease / Issue 12/2007
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI: https://doi.org/10.1007/s00384-007-0354-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

C-reactive protein as early predictor for infectious postoperative complications in rectal surgery

Abstract

Background

Materials and methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Materials and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 12/2007

1% Hydrocortisone ointment is an effective treatment of pruritus ani: a pilot randomized controlled crossover trial

“Fast-track” rehabilitation after colonic surgery in elderly patients—is it feasible?

Substance P induces intestinal wound healing via fibroblasts—evidence for a TGF-β-dependent effect

Role of l-glutamine and glycine supplementation on irradiated colonic wall

The proinflammatory CXC-chemokines GRO-α/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids

Reticulated platelet levels in patients with ulcerative colitis